{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:37:51Z","timestamp":1793047071617,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.schres.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:49:34Z","timestamp":1781855374000},"page":"253-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis"],"prefix":"10.1016","volume":"295","author":[{"given":"Daniele","family":"Cavaleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Crocamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Cucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.06.015_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1016\/j.schres.2026.06.015_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.schres.2026.06.015_bb0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eclinm.2023.102199","article-title":"Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals","volume":"64","author":"Argote","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.schres.2026.06.015_bb0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2021.04.008","article-title":"The kynurenine pathway in schizophrenia and other mental disorders: insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites","volume":"232","author":"Bartoli","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.06.015_bb0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpsychires.2021.09.018","article-title":"Repurposed drugs as adjunctive treatments for mania and bipolar depression: a meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials","volume":"143","author":"Bartoli","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.06.015_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2024.111990","article-title":"Clinical and metabolic correlates of DSM-5 mixed features in subjects with bipolar depression and mania: a cross-sectional study","volume":"188","author":"Bartoli","year":"2025","journal-title":"J. Psychosom. Res."},{"issue":"5","key":"10.1016\/j.schres.2026.06.015_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bbi.2022.07.006","article-title":"Neutrophil-lymphocyte ratios as inflammatory biomarkers in psychiatric patients","volume":"105","author":"Bhikram","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.schres.2026.06.015_bb0045","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/schbul\/sbac089","article-title":"Neutrophil-to-lymphocyte ratio in patients with a first episode of psychosis: a two-year longitudinal follow-up study","volume":"48","author":"Bioque","year":"2022","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","article-title":"Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study","volume":"173","author":"Bloomfield","year":"2016","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.schres.2026.06.015_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-036859","article-title":"Neutrophil-lymphocyte ratio across psychiatric diagnoses: a cross-sectional study using electronic health records","volume":"10","author":"Brinn","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.schres.2026.06.015_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.schres.2022.04.009","article-title":"Influence of positive and negative symptoms on hedonic and eudaemonic well-being in people with schizophrenia: a longitudinal analysis from the EuroSc study","volume":"244","author":"Carr\u00e0","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.06.015_bb0065","article-title":"Complete blood count-based inflammation indexes and symptom severity in people with schizophrenia spectrum disorders: an analysis based on structural equation modelling","volume":"168","author":"Cavaleri","year":"2025","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12991-025-00556-y","article-title":"Exploring the predictive role of the first mood episode on the predominant polarity in bipolar disorder: insights from a path analysis","volume":"24","author":"Cavaleri","year":"2025","journal-title":"Ann. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0075","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2026.10174","article-title":"Complete blood count-based inflammatory ratios in people with bipolar disorder: a systematic review and meta-analysis of neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios","volume":"69","author":"Cavaleri","year":"2026","journal-title":"Eur. Psychiatry."},{"issue":"5","key":"10.1016\/j.schres.2026.06.015_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2023.11.029","article-title":"Immune cell alterations in psychotic disorders: a comprehensive systematic review and meta-analysis","volume":"96","author":"Clausen","year":"2024","journal-title":"Biol. Psychiatry."},{"issue":"12","key":"10.1016\/j.schres.2026.06.015_bb0085","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1017\/S0033291709990651","article-title":"Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?","volume":"39","author":"Demjaha","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.06.015_bb0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/NDT.S299462","article-title":"Monocyte-to-lymphocyte ratio is associated with depression 3 months after stroke","volume":"17","author":"Ding","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2026.06.015_bb0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jad.2025.03.139","article-title":"The U-shape relationship between the aggregate index of systemic inflammation and depression in American adults: a cross-sectional study","volume":"380","author":"Duan","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.schres.2026.06.015_bb0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2026.06.015_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","article-title":"Peripheral immune markers and antipsychotic non-response in psychosis","volume":"230","author":"Enache","year":"2021","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/wps.20481","article-title":"The promise and challenges of drug repurposing in psychiatry","volume":"17","author":"Fava","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12888-023-05101-3","article-title":"Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis","volume":"23","author":"Fekih-Romdhane","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0120","series-title":"User\u2019s guide for the SCID-5-CV structured clinical interview for DSM-5 disorders: Clinical version","author":"First","year":"2016"},{"issue":"4","key":"10.1016\/j.schres.2026.06.015_bb0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","article-title":"The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases","volume":"39","author":"Gasparyan","year":"2019","journal-title":"Ann. Lab. Med."},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2215-0366(14)70245-7","article-title":"Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis","volume":"1","author":"Girardin","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00046","article-title":"Inflammation and negative symptoms of schizophrenia: implications for reward processing and motivational deficits","volume":"11","author":"Goldsmith","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2026.06.015_bb0140","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.06.015_bb0145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.06.015_bb0150","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/schbul\/sbq031","article-title":"Dopaminergic dysfunction in schizophrenia: salience attribution revisited","volume":"36","author":"Heinz","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.06.015_bb0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/NDT.S506074","article-title":"Correlation between monocyte count, monocyte-lymphocyte ratio, and other inflammatory cells with sleep and psychiatric symptoms in first-episode schizophrenia patients","volume":"21","author":"Hu","year":"2025","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2026.06.015_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2026.1782134","article-title":"Peripheral blood immune markers associated with negative symptoms in first episode psychosis: a systematic review","volume":"17","author":"Ingabire","year":"2026","journal-title":"Front. Psychiatry."},{"issue":"2","key":"10.1016\/j.schres.2026.06.015_bb0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5152\/alphapsychiatry.2024.231437","article-title":"Quality of life and C-reactive protein in patients with schizophrenia: a cross-sectional study","volume":"25","author":"Kachouchi","year":"2024","journal-title":"Alpha Psychiatry"},{"issue":"23","key":"10.1016\/j.schres.2026.06.015_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.schres.2026.06.015_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2018.12.017","article-title":"Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis","volume":"206","author":"Karageorgiou","year":"2019","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.06.015_bb0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2026.06.015_bb0185","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: Implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2026.06.015_bb0190","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","article-title":"Inflammation and schizophrenia","volume":"39","author":"Kirkpatrick","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2026.06.015_bb0195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0200","article-title":"The potential predictive value and relationship of blood-based inflammatory markers with the clinical symptoms of Han Chinese patients with first-episode adolescent-onset schizophrenia","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.schres.2026.06.015_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.110959","article-title":"The neutrophil-lymphocyte ratio in first-episode medication-na\u00efve patients with schizophrenia: a 12-week longitudinal follow-up study","volume":"131","author":"Lu","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.06.015_bb0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","article-title":"Schizophrenia, dopamine and the striatum: from biology to symptoms","volume":"42","author":"McCutcheon","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.schres.2026.06.015_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.649494","article-title":"Monocyte transcriptional profiling highlights a shift in immune signatures over the course of illness in schizophrenia","volume":"12","author":"Melbourne","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2026.06.015_bb0220","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105200","article-title":"Immune-inflammatory markers and psychosis risk: a systematic review and meta-analysis","volume":"127","author":"Misiak","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2026.06.015_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114807","article-title":"Relationship between blood-based inflammatory indices and clinical score of schizophrenia patients: a cross-sectional study","volume":"460","author":"Mojadadi","year":"2024","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.schres.2026.06.015_bb0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.psychres.2017.11.086","article-title":"Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosis","volume":"260","author":"Moody","year":"2018","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0240","first-page":"31","article-title":"COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence","volume":"11","author":"M\u00fcller","year":"2010","journal-title":"Curr. Opin. Investig. Drugs."},{"issue":"5","key":"10.1016\/j.schres.2026.06.015_bb0245","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"M\u00fcller","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.06.015_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.schres.2026.06.015_bb0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2012.10.022","article-title":"The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia","volume":"48","author":"Na","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70097-z","article-title":"Relative value of novel systemic immune-inflammatory indices and classical hematological parameters in predicting depression, suicide attempts and treatment response","volume":"14","author":"Ninla-Aesong","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.06.015_bb0265","doi-asserted-by":"crossref","first-page":"10181","DOI":"10.2147\/JIR.S531272","article-title":"The clinical value of systemic immune inflammatory index in predicting the prognosis of patients with bloodstream infection","volume":"18","author":"Ou","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.schres.2026.06.015_bb0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psychres.2018.11.043","article-title":"Neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios in different stages of schizophrenia","volume":"271","author":"\u00d6zdin","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.06.015_bb0275","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41380-018-0058-9","article-title":"Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models","volume":"24","author":"Pillinger","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.06.015_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-23765-7","article-title":"Systemic inflammatory indices comprising monocytes provide a clinical significance for thyroid cancer identification","volume":"15","author":"Refaat","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.06.015_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-025-00600-6","article-title":"COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophrenia","volume":"11","author":"Roithmeier","year":"2025","journal-title":"Schizophrenia"},{"issue":"2","key":"10.1016\/j.schres.2026.06.015_bb0295","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/biom13020297","article-title":"The associations of neutrophil-lymphocyte, platelet-lymphocyte, monocyte-lymphocyte ratios and immune-inflammation index with negative symptoms in patients with schizophrenia","volume":"13","author":"\u0160agud","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.schres.2026.06.015_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.728990","article-title":"Is elevated neutrophil count and neutrophil-to-lymphocyte ratio a cause or consequence of schizophrenia? A scoping review","volume":"12","author":"Sandberg","year":"2021","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.schres.2026.06.015_bb0305","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.schres.2026.06.015_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115764","article-title":"Biochemical aspects of the inflammatory process: a narrative review","volume":"168","author":"Soares","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.schres.2026.06.015_bb0315","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.06.015_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-024-01805-6","article-title":"Network-based drug repurposing for schizophrenia","author":"Truong","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.06.015_bb0325","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","article-title":"Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia","volume":"137","author":"Wallwork","year":"2012","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0330","article-title":"The neutrophil-to-lymphocyte ratio is associated with clinical symptoms in first-episode medication-na\u00efve patients with schizophrenia","volume":"10","author":"Wang","year":"2024","journal-title":"Schizophrenia"},{"issue":"11","key":"10.1016\/j.schres.2026.06.015_bb0335","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/jamapsychiatry.2018.2467","article-title":"Mapping the heterogeneous phenotype of schizophrenia and bipolar disorder using normative models","volume":"75","author":"Wolfers","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants","volume":"333","author":"World Medical Association","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2026.06.015_bb0345","article-title":"Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders","volume":"22","author":"Zhang","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"issue":"3","key":"10.1016\/j.schres.2026.06.015_bb0350","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4103\/NRR.NRR-D-23-01508","article-title":"Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: reflections on therapeutic strategies","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.06.015_bb0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/10398562211022753","article-title":"Neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios in schizophrenia","volume":"30","author":"Zhu","year":"2022","journal-title":"Australas. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:07:12Z","timestamp":1793045232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":71,"alternative-id":["S0920996426001982"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.06.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}